SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as discussions revolve around its performance at the Salinas Airshow, particularly regarding the lack of a vertical takeoff demonstration. While some investors express concerns about this and the company's revenue, others remain bullish, anticipating potential catalysts like piloted VTOL flights and future defense contracts. The stock's high short interest is also fueling speculation about a potential squeeze.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as the community rallies around its potential as the 'Bitcoin of memes' and a representation of the entire crypto industry. Discussions highlight the token's timeless narrative centered on Satoshi Nakamoto, the pseudonymous creator of Bitcoin, and its strong community. Some users are celebrating the project's two-year anniversary.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending amid community anticipation for a major partnership announcement and excitement around its integration with the AllUnity EURAU stablecoin. The potential for partnerships with major institutions and the upcoming Uphold partnership reveal are key talking points. Additionally, speculation about Zebec's compliance with MiCA regulations in Europe has generated significant buzz.

DinkDoink Token

DinkDoink Token ($DINK) is trending amid mixed community sentiment, with some users excited about potential celebrity endorsements (including Logan Paul) and its multimedia concept, while others express concerns about it being a potential scam. The project aims to create a cartoon series based on the token, differentiating it from other meme coins, but some users are drawing comparisons to other social media influencer-related crypto projects.

Energous Corp. engages in the development of wireless charging technology. It focuses on the product, WattUp, a wireless power technology consisting of proprietary semiconductor chipsets, software controls, hardware designs, and antennas, that enables radio frequency based charging for electronic devices. The company was founded by Michael Aaron Leabman in 2012 and is headquartered in San Jose, CA.

Energous Corp

Energous is trending as community members debate the potential impact of Walmart's partnership with Wiliot, a company that uses Energous' wireless power technology, on $WATT's stock. Discussions revolve around whether Energous is undervalued, the potential for a merger with Wiliot, and the significance of recent executive activity. Some traders express concern about the company's history and the possibility of another reverse stock split.

Anoma is the decentralized OS powering a unified app layer for all Web3. With Anoma, developers can write one app that works on any chain. Anoma frees developers from the complexity of infrastructure so they can focus on what matters: building apps and experiences that people love. Anoma introduces a next-gen intent-centric architecture optimized for app development and UX, enabling Web3 to support a rich ecosystem of apps that can finally compete with the functionality and experience of Web2.

Anoma

XAN is seeing volatile discussion as traders assess its potential after a recent listing. Community members are debating entry and exit points, with some anticipating a price rebound while others express concerns about tokenomics and airdrop impacts. The conversation includes comparisons to other interoperability projects and speculation about future partnerships.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

XRPI is trending due to speculation around potential price appreciation fueled by Ripple's partnerships, including a possible BlackRock collaboration, and the possibility of an XRP ETF or trust. Community members are actively discussing entry points and potential ROI, while others debate the validity and timing of predicted price movements. The broader context involves discussions around asset tokenization and XRP's role in global payment systems.

Valvoline, Inc. engages in the production, marketing, and supply of engine and automotive maintenance products and services. It operates through the Retail Services segment. The Retail Services segment services the passenger car and light truck quick lube market in the US and Canada with preventive maintenance services done through company operated and independent franchise care stores. The company was founded by John Ellis in 1866 and is headquartered in Lexington, KY.

Valvoline Inc

Valvoline ($VVV) is trending as investors discuss its potential to test all-time highs, driven by expansion plans including new store openings and the acquisition of Breeze. The community highlights the company's safe, long-term hold prospects, especially with its entry into electric vehicle services. Bullish sentiment is also fueled by financial statement analysis indicating a healthy financial outlook.

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Mind Medicine Inc

Mind Medicine Inc - Ordinary Shares (Sub Voting)

MNMD is trending as the community discusses potential catalysts, including positive trial data and regulatory developments in the psychedelics sector.  Bullish sentiment is fueled by the anticipation of significant price appreciation and potential buyouts, with the company's strong cash position and ongoing Phase 3 trials cited as key factors. Discussions also involve the broader context of psychedelic medicine's growing acceptance and potential to revolutionize mental health treatment.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community emphasizes its strong cultural ties and compares it favorably to Bitcoin. Community members are sharing links to the project's website, social media, and trading charts. The conversation highlights the crypto's longevity and continued relevance within its niche.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Buy Rating Affirmed for SCYNEXIS on Ibrexafungerp Success and Strong GSK Partnership

Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on SCYNEXIS (SCYX Research Report) today and set a price target of $7.50...

SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of...

Scynexis reports FY23 EPS $1.39, consensus $1.42

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update

SCY-247's IND-enabling activities continue to advance with initiation of Phase I anticipated in the second half of 2024 Data analysis for the FURI study is ongoing; top line data from the CARES...

Lacklustre Performance Is Driving SCYNEXIS, Inc.'s (NASDAQ:SCYX) Low P/S

With a price-to-sales (or "P/S") ratio of 0.6x SCYNEXIS, Inc. ( NASDAQ:SCYX ) may be sending very bullish signals at...

SCYNEXIS to Participate in Guggenheim's 6th Annual Biotechnology Conference

JERSEY CITY, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and...

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

In vivo data demonstrated response rate for oral SCY-247 similar to current standard of care, intravenous Liposomal Amphotericin B, for the treatment of mucormycosisCombination of SCY-247 and...

DEADLINE ALERT for SCYX, LICY, and FMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...

SCYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SCYNEXIS, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been...

Final SCYX Investor Deadline: Bronstein, Gewirtz & Grossman LLC Announces that SCYNEXIS, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Final SCYX Investor Deadline: Bronstein, Gewirtz & Grossman LLC Announces that SCYNEXIS, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Final SCYX Investor...

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

Scynexis Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$0.80
Prev Close	$0.7963
Open	$0.80
Dividend Yield	0.00%
50-Day Moving Average	$0.8844
Beta	1.16
Avg. Volume	505,303.67
PE Ratio	-1.90

52-Week High	$1.62
52-Week Low	$0.66
Market Capitalization	$33.54M
EPS (Annual)	-$0.4388
Price to Book	0.70
Revenue Per Employee	$133,785.71
Enterprise Value/EBITDA	N/A

SCYX
Scynexis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SCYX News

SCYX Scynexis Inc